Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | B4LM4 | — |
Shingrix was reconstituted using a different sterile diluent; Shingrix was reconstituted using a different sterile diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 65-year-old male patient who received Herpes zoster (Shingrix) (batch number B4LM4, expiry date 26-AUG-2027) for prophylaxis. On 06-MAR-2026, the patient received Shingrix. On 06-MAR-2026, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Shingrix was reconstituted using a different sterile diluent) and inappropriate dose of vaccine administered (Verbatim: Shingrix was reconstituted using a different sterile diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 10-MAR-2026 The medical assistant mentioned that it was regular sterile diluent. The dose was administered to a patient. The batch number was not provided upon follow up with the reporter.